NITI Aayog to tackle counterfeit drugs with Blockchain technology

medicene

Author: Jagdish Kumar, India

With a view to take on counterfeit drugs in the country, National Institution for Transforming India (NITI) Aayog have joined hands with Cloud major Oracle, Apollo Hospitals and global pharmaceutical manufacturer Strides Pharma Sciences to pilot a real drug supply chain, using Blockchain decentralised ledger and Internet of Things (IoT) software.

The policy think tank of the Indian government established with the aim to achieve Sustainable Development Goals is looking to cut the source of counterfeit drugs available in the global market by bringing transparency, accountability and efficiency in tracing and tracking drugs manufactured in the country.

The agreement was signed by Anna Roy, Advisor (Industry), NITI Aayog and Shailender Kumar, Regional Managing Director, Oracle India, in the presence of Amitabh Kant, CEO, NITI Aayog and Sangita Reddy, Joint Managing Director, Apollo Hospitals.

Speaking on this, Oracle MD said that India is the third largest producer of generic drugs and vaccines globally and we’ve been exporting to almost 200 countries. But 20% of the drugs being circulated in the Indian market are fake.

According to World Health Organization (WHO), India being the largest producer of generic drugs in the world is also said to be the source of 35% of all counterfeit drugs sold world-wide.

Kumar adding further said that its Blockchain software permanently registers a drug’s record in the manufacturer’s drug supply chain (serial number, labelling and scanning), thus leaving very little scope for record tampering.

From the start, the software records the drug’s movement from manufacturer to logistics, from stockist to hospital, or from pharmacy to consumer and if any fake drug are found in the process, the software will detect the irregularity and notify the concerned nodal point.

NITI Aayog CEO said that the agreement will help ensure all Indian drug manufacturers and healthcare experts have access to a standards-based, modern technology platform using Blockchain and IoT to eliminate fake drug distribution.

Kumar said that with Blockchain, every movement of the drug through its supply chain is recorded. That way, the drug supply chain is completely transparent, secure, decentralized and verifiable. Blockchain and IoT can play a significant role in ceasing fake drug distribution.

Oracle IoT also provides functionality to track critical information such as chemical ingredients of the drug or maintenance of temperature control in case of life saving drugs or vaccines.

Image credit: media.everus.org

jagdish@bitcoinlinux.com

The post NITI Aayog to tackle counterfeit drugs with Blockchain technology appeared first on bitcoinlinux.com.

Sending
User Review
0 (0 votes)